inclusion criteria: * confirmed sars-cov-2 and * requiring at least 10l/min of o2 supplementation, non-invasive mechanical ventilation for hypoxia or invasive mechanical and

inclusion criteria: * confirmed sars-cov-2 and * requiring at least 10l/min of o2 supplementation, non-invasive mechanical ventilation for hypoxia or invasive mechanical and

inclusion criteria: confirmed sars-cov-2 and requiring at least 10l/min of o2 supplementation, non-invasive mechanical ventilation for hypoxia or invasive mechanical and

inclusion criteria: confirmed sars-cov-2 and requiring at least 10l/min of o2 supplementation, non-invasive mechanical ventilation for hypoxia or invasive mechanical and

previously randomized to the cs-2 trial if they had received corticosteroids for covid-19 during ≥5 consecutive days or use corticosteroids in doses >6 mg dexamethasone for an indication other than covid-19. active tuberculosis hypersensitivity to dexa-/betamethasone active fungal infection fertile woman ≤60 years of age with a positive u-hcg/p-hcg test established thromboembolism at randomization. informed consent not obtainable

previously randomized to the cs-2 trial if they had received corticosteroids for covid-19 during ≥5 consecutive days or use corticosteroids in doses >6 mg dexamethasone for an indication other than covid-19. active tuberculosis hypersensitivity to dexa-/betamethasone active fungal infection fertile woman ≤60 years of age with a positive u-hcg/p-hcg test established thromboembolism at randomization. informed consent not obtainable